Polymyalgia rheumatica during combination therapy with atezolizumab plus bevacizumab for advanced hepatocellular carcinoma.

Dosoden, Naoki; Kuzuya, Teiji; Ito, Yumi; Nishino, Jo; Ohno, Eizaburo; Kawabe, Naoto; Hashimoto, Senju; Hirooka, Yoshiki; Yasuoka, Hidekata

Dosoden, Naoki; Kuzuya, Teiji; Ito, Yumi; Nishino, Jo; Ohno, Eizaburo; Kawabe, Naoto; Hashimoto, Senju; Hirooka, Yoshiki; Yasuoka, Hidekata.

Afiliação

Dosoden N; Division of Rheumatology, Department of Internal Medicine, Fujita Health University, Toyoake, Japan.
Kuzuya T; Department of Gastroenterology and Hepatology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. teiji.kuzuya@fujita-hu.ac.jp.
Ito Y; Division of Rheumatology, Department of Internal Medicine, Fujita Health University, Toyoake, Japan.
Nishino J; Division of Rheumatology, Department of Internal Medicine, Fujita Health University, Toyoake, Japan.
Ohno E; Department of Gastroenterology and Hepatology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Kawabe N; Department of Gastroenterology and Hepatology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Hashimoto S; Department of Gastroenterology and Hepatology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Hirooka Y; Department of Gastroenterology and Hepatology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Yasuoka H; Division of Rheumatology, Department of Internal Medicine, Fujita Health University, Toyoake, Japan.

Clin J Gastroenterol ; 16(4): 567-571, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37071371

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Polimialgia Reumática; Humanos; Polimialgia Reumática/tratamento farmacológico; Polimialgia Reumática/diagnóstico; Carcinoma Hepatocelular/tratamento farmacológico; Bevacizumab/efeitos adversos; Proteína C-Reativa/uso terapêutico; Neoplasias Hepáticas/tratamento farmacológico; Prednisolona/uso terapêutico

Palavras-chave

Atezolizumab; Hepatocellular carcinoma; Immune-related adverse events; Polymyalgia rheumatica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimialgia Reumática / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google